7Baggers
 td cowen maintains repare therapeutics(rptx.us) with buy rating  富途牛牛 Sun, 28 Sep 2025 06:38:32 GMT
 Repare Therapeutics (NASDAQ:RPTX) Shares Down 0.6% - Time to Sell?  MarketBeat Wed, 24 Sep 2025 06:37:02 GMT
 published on: 2025-09-22 10:35:25  newser.com Mon, 22 Sep 2025 15:35:25 GMT
 published on: 2025-09-17 14:44:09  newser.com Wed, 17 Sep 2025 19:44:09 GMT
 repare therapeutics describes new polθ inhibitors  BioWorld MedTech Mon, 15 Sep 2025 13:00:00 GMT
 published on: 2025-09-11 23:07:51  Newser Fri, 12 Sep 2025 04:07:51 GMT
 mpm bioimpact llc trims position in repare therapeutics inc. $rptx  MarketBeat Thu, 04 Sep 2025 11:08:49 GMT
 does anyone know about the stock repare theraputics and penn?  AInvest Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-08-28 03:21:30  Newser Thu, 28 Aug 2025 08:21:30 GMT
 published on: 2025-08-26 23:59:50  Newser Wed, 27 Aug 2025 04:59:50 GMT
 published on: 2025-08-26 09:26:51  Newser Tue, 26 Aug 2025 14:26:51 GMT
 published on: 2025-08-24 18:12:43  theviewers.co.kr Sun, 24 Aug 2025 09:12:43 GMT
 published on: 2025-08-22 15:49:55  Newser Fri, 22 Aug 2025 20:49:55 GMT

Repare Therapeutics Inc.
(NASDAQ:RPTX) 

RPTX stock logo

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validat...

Founded: 2016
Full Time Employees: 180
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends